Carcinoid syndrome causes

Revision as of 16:17, 23 April 2019 by Anum Gull (talk | contribs) (→‎Causes)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

Carcinoid syndrome Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Carcinoid Syndrome from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Staging

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

Chest X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Carcinoid syndrome causes On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Carcinoid syndrome causes

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Carcinoid syndrome causes

CDC on Carcinoid syndrome causes

Carcinoid syndrome causes in the news

Blogs on Carcinoid syndrome causes

Directions to Hospitals Treating Carcinoid syndrome

Risk calculators and risk factors for Carcinoid syndrome causes

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]Associate Editor(s)-in-Chief: Parminder Dhingra, M.D. [2]

Overview

Common causes of carcinoid syndrome include genetic disorders (multiple endocrine neoplasia type 1 and neurofibromatosis type 1) and genetic mutations (gains involving chromosomes 5, 14, 17, and 19 and losses involving chromosomes 11 and 18).

Causes

[4][5]

Genetic Disorder Tumor Location

Multiple endocrine neoplasia type 1

Neurofibromatosis type 1

Type of Mutation Chromosomes

Gains

Losses

References

  1. Rubin de Celis Ferrari AC, Glasberg J, Riechelmann RP (August 2018). "Carcinoid syndrome: update on the pathophysiology and treatment". Clinics (Sao Paulo). 73 (suppl 1): e490s. doi:10.6061/clinics/2018/e490s. PMC 6096975. PMID 30133565.
  2. Molecular genetics. National Cancer Institute. http://www.cancer.gov/types/gi-carcinoid-tumors/hp/gi-carcinoid-treatment-pdq
  3. "Duodenal Carcinoid Tumours, Phaeochromocytoma and Neurofibromatosis: Islet Cell Tumour, Phaeochromocytoma and the Von Hippel-Lindau Complex: Two Distinctive Neuroendocrine Syndromes". QJM: An International Journal of Medicine. 1987. doi:10.1093/oxfordjournals.qjmed.a068147. ISSN 1460-2393.
  4. Jakobovitz, O; Nass, D; DeMarco, L; Barbosa, A J; Simoni, F B; Rechavi, G; Friedman, E (1996). "Carcinoid tumors frequently display genetic abnormalities involving chromosome 11". The Journal of Clinical Endocrinology & Metabolism. 81 (9): 3164–3167. doi:10.1210/jcem.81.9.8784062. ISSN 0021-972X.
  5. O'Shea T, Druce M (December 2017). "When should genetic testing be performed in patients with neuroendocrine tumours?". Rev Endocr Metab Disord. 18 (4): 499–515. doi:10.1007/s11154-017-9430-3. PMC 5849652. PMID 28965289.

Template:WH Template:WS